CN1332638A - 包含β－激动剂和其它抗糖尿病药物的组合物 - Google Patents

包含β－激动剂和其它抗糖尿病药物的组合物 Download PDF

Info

Publication number
CN1332638A
CN1332638A CN99815382A CN99815382A CN1332638A CN 1332638 A CN1332638 A CN 1332638A CN 99815382 A CN99815382 A CN 99815382A CN 99815382 A CN99815382 A CN 99815382A CN 1332638 A CN1332638 A CN 1332638A
Authority
CN
China
Prior art keywords
beta
insulin
antidiabetic drug
agonists
another kind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99815382A
Other languages
English (en)
Chinese (zh)
Inventor
J·R·S·哈洛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1332638A publication Critical patent/CN1332638A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CN99815382A 1998-11-11 1999-11-11 包含β－激动剂和其它抗糖尿病药物的组合物 Pending CN1332638A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GB9824789.3 1998-11-11
GB9824790.1 1998-11-11
GB9824791.9 1998-11-11

Publications (1)

Publication Number Publication Date
CN1332638A true CN1332638A (zh) 2002-01-23

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99815382A Pending CN1332638A (zh) 1998-11-11 1999-11-11 包含β－激动剂和其它抗糖尿病药物的组合物

Country Status (15)

Country Link
EP (1) EP1128845A1 (tr)
JP (1) JP2002529430A (tr)
KR (1) KR20010075698A (tr)
CN (1) CN1332638A (tr)
AU (1) AU766928B2 (tr)
BR (1) BR9915214A (tr)
CA (1) CA2350062A1 (tr)
CZ (1) CZ20011655A3 (tr)
HK (1) HK1041201A1 (tr)
HU (1) HUP0104388A3 (tr)
IL (1) IL143004A0 (tr)
NO (1) NO20012300L (tr)
PL (1) PL348154A1 (tr)
TR (1) TR200101336T2 (tr)
WO (1) WO2000027434A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU777776B2 (en) 1999-12-23 2004-10-28 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
WO2001047509A2 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0170416B1 (ko) * 1990-02-09 1999-02-18 로버트 에이. 아미테이지 고혈압 치료를 위한 인슐린 증감제의 용도
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE251608T1 (de) * 1996-01-10 2003-10-15 Asahi Chemical Ind Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Also Published As

Publication number Publication date
NO20012300D0 (no) 2001-05-10
JP2002529430A (ja) 2002-09-10
CA2350062A1 (en) 2000-05-18
TR200101336T2 (tr) 2001-11-21
WO2000027434A1 (en) 2000-05-18
EP1128845A1 (en) 2001-09-05
KR20010075698A (ko) 2001-08-09
CZ20011655A3 (cs) 2002-06-12
AU766928B2 (en) 2003-10-23
NO20012300L (no) 2001-07-03
PL348154A1 (en) 2002-05-06
BR9915214A (pt) 2001-12-18
HK1041201A1 (zh) 2002-07-05
HUP0104388A3 (en) 2002-12-28
IL143004A0 (en) 2002-04-21
AU1063400A (en) 2000-05-29
HUP0104388A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
CN1443068A (zh) 用于治疗糖尿病的二肽基肽酶iv抑制剂和其它抗糖尿病药剂的组合用药物
CN1114404C (zh) 用噻唑烷二酮和二甲双胍治疗糖尿病
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
CN1332638A (zh) 包含β－激动剂和其它抗糖尿病药物的组合物
KR20010013843A (ko) 로지글리타존 및 인슐린을 사용한 당뇨병의 치료
CN1168451C (zh) 噻唑烷二酮和磺酰脲组合物在制备治疗糖尿病的药物中的用途
CN1263467A (zh) 用噻唑烷二酮、促胰岛素分泌剂和α一葡糖苷酶抑制剂治疗糖尿病
RU2664442C2 (ru) Способ снижения веса
CN1274282A (zh) 用噻唑烷二酮和α－葡糖苷酶抑制剂治疗糖尿病
CN1235586C (zh) 改进释放组合物及其用途
JP2005515984A (ja) メトホルミンと４−オキソブタン酸の組合せを有する薬剤組成物、および糖尿病治療へのその適用
CN1976696A (zh) 用于预防或治疗脂质代谢异常的医药组合物
US20030073644A1 (en) Combinations comprising a beta-agonist and a further antidiabetic agent
WO2008026668A1 (fr) Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
ZA200103792B (en) Combinations comprising a beta-agonist and a further antidiabetic agent.
CN101040854A (zh) 用噻唑烷二酮和二甲双胍治疗糖尿病
CN1281359A (zh) 应用噻唑烷二酮类药物治疗高血糖症
CN1281358A (zh) 噻唑烷二酮在高血糖症治疗中的应用
CN1599608A (zh) 含有格列酮和4－氧代丁酸的药物组合物以及它们治疗糖尿病的用途

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication